Work

Abstract 7297: Enhanced efficacy of CTX-471, a CD137 agonist antibody, in models of immune checkpoint failure via simultaneous blockade of neo-angiogenesis

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-7297

Authors: Amy Daniel Ulumben, Diana I. Albu, Rachael Duffy, Tristan Lubinski, Jason Kong, Jessica Zolotaresvsky, Melissa Brundin, Mei Su, Ruturaj Jadhav, Bing Gong, Thomas Schuetz, Kris Sachsenmeier, Alberto Visintin

Institution: Compass Therapeutics, Inc. (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409630629

Cites:

Cited by: 1

Related to: 10